Valuation: Orion Oyj

Market Cap 14.45B 15.95B 13.37B 12.06B 22.73B 1,504B 23.53B 161B 63.67B 803B 59.85B 58.58B 2,550B P/E 2026 *
23.8x
P/E 2027 * 20.4x
Enterprise Value 14.33B 15.82B 13.26B 11.96B 22.54B 1,491B 23.34B 159B 63.15B 797B 59.36B 58.1B 2,529B EV / Sales 2026 *
6.8x
EV / Sales 2027 * 5.84x
Free-Float
90.18%
Yield 2026 *
1.89%
Yield 2027 * 2.23%
1 day+0.29%
1 week+0.98%
Current month+3.00%
1 month+19.84%
3 months+33.07%
6 months+52.93%
Current year+61.82%
1 week 101.1
Extreme 101.1
104
1 month 85.95
Extreme 85.95
104
Current year 62.7
Extreme 62.7
104
1 year 58.85
Extreme 58.85
104
3 years 31.86
Extreme 31.86
104
5 years 31.86
Extreme 31.86
104
10 years 22.57
Extreme 22.57
104
Manager TitleAgeSince
Chief Executive Officer 59 2022-10-31
Director of Finance/CFO 50 2024-04-30
Chief Operating Officer 46 2021-12-31
Director TitleAgeSince
Director/Board Member 63 2017-03-21
Director/Board Member 65 2017-03-21
Director/Board Member 66 2020-05-05
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Sell

Chief Operating Officer

4,000 0.0122%
8/4/25 Sell

Executive/Senior Manager

71 0.0002%
8/4/25 Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.29%+0.98%+71.67%+172.20% 15.95B
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average +0.27%+1.97%+39.02%+92.25% 431B
Weighted average by Cap. +0.54%+3.25%+37.82%+96.78%

Financials

2026 *2027 *
Net sales 2.11B 2.33B 1.95B 1.76B 3.31B 219B 3.43B 23.42B 9.29B 117B 8.73B 8.54B 372B 2.41B 2.66B 2.23B 2.01B 3.79B 251B 3.92B 26.78B 10.62B 134B 9.98B 9.77B 425B
Net income 608M 671M 562M 507M 956M 63.22B 989M 6.75B 2.68B 33.77B 2.52B 2.46B 107B 711M 785M 658M 593M 1.12B 73.97B 1.16B 7.9B 3.13B 39.51B 2.94B 2.88B 125B
Net Debt -117M -129M -108M -97.77M -184M -12.19B -191M -1.3B -516M -6.51B -485M -475M -20.67B -377M -416M -349M -315M -594M -39.27B -614M -4.19B -1.66B -20.98B -1.56B -1.53B -66.59B
Projected Income Statement - Annual - Orion Oyj
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,215
Date Price Change Volume
26-11-13 €103.00 +0.29% 111,333
26-11-12 €102.70 -0.10% 143,630
26-11-11 €102.80 +0.88% 151,259
26-11-10 €101.90 -0.29% 168,447
26-11-09 €102.20 +0.20% 99,944
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Orion Oyj
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
103.00EUR
Average target price
87.50EUR
Spread / Average Target
-15.05%
  1. Stock Market
  2. Stocks
  3. ORNBV Stock